Springer Nature
Browse
12931_2017_543_MOESM3_ESM.doc (47.5 kB)

Additional file 3: of Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients

Download (47.5 kB)
journal contribution
posted on 2017-04-17, 05:00 authored by Florian M. Karl, Rolf Holle, Robert Bals, Timm Greulich, Rudolf Jörres, Annika Karch, Armin Koch, Stefan Karrasch, Reiner Leidl, Holger Schulz, Claus Vogelmeier, Margarethe Wacker
Significant estimates on a level of p < .05 are printed bold. A = COPD patients without Alpha-1-antitrypsin deficiency (AATD), B1 = COPD patients with AATD and augmentation therapy (AT), B2 = COPD patients with AATD but without AT. EQ-5D-3 L values are given after multiplication by 100. (DOC 47 kb)

Funding

Bundesministerium für Bildung und Forschung

History